A comparative evaluation of the angiopoietin-like protein 8 (ANGPTL8) and alarin levels in patients with type 2 diabetes mellitus
Abstract
Purpose: Type 2 Diabetes Mellitus (T2DM) is one of the most serious public health problems that affect millions of people worldwide. There are 537 million adults diagnosed with diabetes worldwide and approximately 90% of these adults have type 2 diabetes. The study examined angiopoietin-like protein 8 (ANGPTL8) and Alarin levels of the patients diagnosed with T2DM in comparison with each other and with the healthy control group.
Materials and Methods: The study was conducted with a diabetes group consisting of 67 patients who were newly diagnosed with T2DM and who did not use any medication, and the control group consisting of 55 healthy people. ANGPTL8 and Alarin levels were measured using the ELISA (enzyme-linked immunosorbent assay) method.
Results: We found a significant increase in alarin and ANGPTL8 levels in the diabetic group compared to the control group. Furthermore, a positive correlation between Alarin levels and ANGPTL8, triglyceride, and insulin levels was found in the patient group. In addition, while both adipokines were higher in males in the patient group, both adipokines levels were lower in males than females in the control group, and there was a significant difference in ANGPTL8 levels.
Conclusion: High levels of ANGPTL8 and Alarin may facilitate the development of diabetes through the insulin resistance pathway. If this mechanism is more clearly elucidated, there may be a significant improvement in diabetic treatment projection.
Keywords
Kaynakça
- Rosen ED, Kaestner KH, Natarajan R, Patti ME, Sallari R, Sander M et al. Epigenetics and epigenomics: Implications for diabetes and obesity. Diabetes. 2018;67:1923–1931.
- IDF Diabetes Atlas 2021. 10th Edition. https://www.idf.org/news/240:diabetes-now-affects-one-in-10-adults-worldwide.html (accessed Feb 2022).
- Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26:19-39.
- Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12-22.
- Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303:334-351
- Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-92.
- Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109:19751-6.
- Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell. 2013;153:747–758.
- Santic R, Fenninger K, Graf K, Schneider R, Hauser KC, Schilling FH et al. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. J Mol Neurosci. 2006;29:145-152.
- Santic R, Schmidhuber SM, Lang R, Rauch I, Voglas E, Eberhard N et al. Alarin is a vasoactive peptide. Proc Natl Acad Sci U S A. 2007;104,10217–10222.
